SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally.
SONTU Medical Imaging Equipment Co Ltd
Founded in 2009, Shenzhen SONTU Medical Imaging Equipment Co., Ltd. is a leading manufacturer of medical imaging systems with independent core technologies. Driven by our mission — “Advancing the quality of care with continuous innovation; empowering the global healthcare system with high-quality imaging” — SONTU dedicated to in-house R&D and manufacturing to deliver cutting-edge imaging solutions. Our core technology portfolio includes flat panel detectors, high-voltage generators, mechanical design, image acquisition and processing systems, and AI-powered imaging platforms, etc. Today, SONTU’s solutions are trusted in over 70 countries and adopted by over 8,000 medical institutions worldwide. Committed to innovation, reliability, and customer satisfaction, SONTU delivers cost-effective, high-performance products that contribute to global health.
Sonoscanner US
Sonoscanner designs and manufactures advanced ultrasound systems for a wide range of clinical applications. Compact, robust, and fast to start-up, they are ideal tools for healthcare professionals across multiple specialties. The ultra-portable platform supports 11 interchangeable transducers and offers all Doppler modes, integrated AI, and exceptional image quality.
Sonostar Technologies Co., Limited
Sonostar is the leading manufacturer of Wireless Ultrasound Scanners in China, our devices have CE MDR, FDA 510K, Health Canada, KFDA, TGA, ANVISA, Russia GOST-R, Turkey, Japan certification, etc., since 2015, there are more than 120 thousands units of our Wireless Ultrasound Scanners installation globally, because our device has very clear image, low cost, small size, Wireless, very easy & convenient for sterilization. Welcome to have OEM/ODM cooperation with Sonostar !
SomaLogic (an Illumina company)
SomaLogic™, an Illumina company, is the only high-plex proteomics technology on the market that scales with precision. It provides the largest number of protein measurements and the greatest number of orthogonally confirmed protein reagents in the proteomics industry – 11,000 protein measurements simultaneously from sample volumes as low as 55 µl. This gives researchers access to half of the human proteome in just one assay. Over a decade of proof in major cardiometabolic, neurology and oncology studies using the SomaScan Platform, sponsored by leading pharma companies with more than 1,200 publications to date, have driven efforts to significantly accelerate trials.
Smartsheet
Smartsheet is the Intelligent Work Management Platform that unites people, data, and AI to eliminate execution silos – turning operational complexity into better patient outcomes. Purpose-built for scale, Smartsheet gives healthcare and life sciences organizations the speed, governance and trust to execute complex work across portfolios, operations and IT on a single, secure system. Smartsheet empowers millions of users to move faster, reduce risk and realize ROI with confidence. Visit www.smartsheet.com to learn more.
Sirona Medical Inc.
Sirona Medical is a San Francisco–based healthcare technology company unifying radiology IT applications — worklist, viewer, reporter, archive, and AI — into a single, cloud-native workspace. Built on its RadOS™ operating system, Sirona enables radiologists to work as fast as they can think through unified, intelligent workflows that connect imaging, data, and reporting in real time. | Sirona Medical is modernizing the core infrastructure of radiology. Powered by its cloud-native RadOS™ operating system, Sirona brings together PACS, diagnostic imaging, reporting, workflow, archive, and AI into a single unified platform. This eliminates data fragmentation, enables real-time collaboration, and creates a continuously learning system—allowing health systems to scale imaging operations today while preparing for an AI-driven future of care.
SiriusXT Ltd
SiriusXT has developed the only commercially-available laboratory instrument that is capable of non-destructively imaging the whole internal structure of intact cells or tissue slabs, with high natural contrast (label-free) and with nanometer-resolution. The microscope, called a Soft X-ray Microscope, uses an imaging modality that has been in use for over 30 years but which has only been available at six global, football stadium-sized, research facilities, called synchrotrons. SiriusXT has effectively miniaturized the synchrotron into a chamber measuring less than 3 feet in diameter, enabling the development of a table-top microscope. This means that the benefits of soft X-ray microscopy are now accessible 24/7, without having to wait for up to 12 months to get access to the synchrotron microscopes. Despite the very restricted access to the synchrotron-based microscopes many hundreds of peer-reviewed papers have been published by scientists working in disease research and therapeutic discovery where the images produced by the microscopes have helped in making significant advances in scientific state of the art. In biological research, Soft X-ray Microscopy can be used as a stand-alone cell and tissue structural imaging technique, where it can image sample thicknesses that are close to 50 times greater than can be imaged with electron microscopy. It can also be used in correlative imaging workflows, along with light and electron microscopy, to greatly increase (by a factor of over 20 times) the sample imaging throughput. Thirdly, it has been demonstrated that Soft X-ray Microscopy provides an effective means for tracking and validating the delivery of nanoparticle, carrying a cargo of therapeutics, vaccines or adjuvants, to targeted end points in cells. SiriusXT has commissioned its first commercial product, the SXT-100, in 2024 at a research university in Europe. It is now focused on introducing the SXT-100 to target customers in the US.